-
This Regulated Generics Stock Rises 36% in 1 Year: Debt Down, Margins Up
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
No Comments
One Bengaluru based formulations maker gained roughly 36% in twelve months on expanding margins and falling debt. Here is what drove it and what could still go wrong.